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5 1 OA ABSTRACTS - Valvular Heart Disease 
els of B-Type natriuretic peptide despite significantly increased LV mass and volumes, 
even in patients with symptoms. Therefore, BNP may not be a useful marker in the man- 
agement and evaluation of patients with chronic MR 
ORAL CONTRIBUTIONS 
841 Clinical Markers Predictive of Outcome in 
Patients With Valvular Heart Disease 
Tuesday, April 01, 2003, 8:30 a.m.-10:OO a.m. 
McCormick Place, Room S101 
8:30 a.m. 
841-I The Effective Regurgitant Orifice Area Is Predictive of 
Survival in Patients With Organic Mitral Regurgitation 
Maurice L. Enriauez-Sarano, A. Jamil Tajrk, David Messika-Zeitoun, Jean-Francois 
Avierinos, Michael Bellamy, Christophe Triboullloy, Mayo Clinic, Rochester, MN 
Background: Quantitation of mitral regurgitation (MR) is possible using Doppler- 
Echocardiography and allows measurement of the Effective Regurgitant orifice (ERO) 
area and of the Regurgitant volume (RVol). However, the implications of these measure- 
ments regarding survival after diagnosis are unknown because no long-term study out- 
come study has yet been conducted. 
Methods: We prospectively enrolled 456 patients with MR due to organic mitral lessons 
(mitral prolapse in 360 or 79%) in whom quantitatlon of MR was obtained at baseline by 
at least 2 independent methods. The end-points analyzed were survival under conserva- 
tive management and the combined end-point of death or mitral surgery. 
Results: At diagnosis, age was 64+14 years and 61% were male, ERO was 41i26 mm2 
(range 2 to 180 mm2) and RVol was 65+40 ml/beat (range 3 to 227). The left ventnculat 
end-diastolic volume was enlarged at 107+26 mUm2 and the ejection fraction was nor- 
mal at 69+9%. The 5.year rates of mortality under conservative management and of sur- 
gery or death were 24+3% and 66+3%. Both ERO and RVol were unwariately predictive 
of these end-points (PcO.001) but in multivariate analysis adjusting for age, sex, func- 
tional class and ejection fraction, only ERO was predictive of suwival (RR 1.22 [1.06- 
1.381 par 10 mm2 increase, P=O.O05). ERO was also independently predictive of death 
or mitral surgery (RR 1.41 [1.29-l ,521 per IO mm2 increase, P-zO.001). 5 years after diag- 
nosis, for patients with ER0<20, 20-30 and X30 mm3. mortality under conservative man- 
agement was 9+3%. 31 +lO% and 49*6%, respectively and death or mitral surgery 
(excluding patients operated within 3 months of diagnosis) was 14*4%, 55*9% and 
63+4%. respectively (both P<O.OOl). 
Conclusion: The present study demonstrates for the first time in patients with organic 
MR. l-the strong outcome implications of quantitative measures of degree of MR, P-the 
preeminent Independent prognostic value for surwal of ERO area. which 3.allows to 
stratify patients into groups at low-, medium- and high-risk. Hence. measurement of ERO 
area of MR is an essential tool in management of patients with orgamc MR. 
6145 a.m. 
841-2 Brain Natriuretic Peptide Predicts Severity of Aortic 
Stenosis 
Johann Auer, Thomas Weber, Robert Berent, Elisabeth Lassnig. Josef Seier, Bernd 
Eber, General Hospital Wels, Wels, Austria 
Background: Bratn natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) consti- 
tute a cardiac hormone system mediating natriuresis, diuresis, and vasodilation. 
Whereas ANP is secreted mainly from cardiac atria, BNP is produced to a larger extent in 
ventricles and has been shown to correlate with end-systolic wall stress in patients with 
aorilc stenosis (AS). Echocardiography with doppler examination of the aortic valve pro- 
vides a vary accurate assessment of the trans.valvular aortic pressure gradient (TVPG) 
and is used to monitor progression of AS. This study evaluated circulating BNP as a 
marker of left ventricular hyperirophy and atrial pressure increase in patients with AS. 
Patients and Methods: We westigated the serum concentrations of BNP by radioimmu- 
noassay in 69 AS patients (35 males, mean age 70,9 years; range 37-90; mean TVPG 
determlned by echocardlography 45,2 mmHg (+I- 20.6). calculated mean aortic valve 
area (AVA) (assessed invasively) 0,65 cm2 (+/- 0.3). TVPG were correlated to the AVA 
(r=O.54, P=O.OOl). Results are expressed as mean (+/- standard deviation), correlations 
were tested by Spearman-rang test and comparisons between group were tested by the 
Mann-Whitney test. 
Results: BNP levels were slgnlficantly higher I” AS patients with AVA less than 1 cm2 
(2558,5 pg/ml; +I- 2555,6) when compared with the patients with AVA more than 1 cm2 
(1567,4 pglml (+/- 2447,9) P=O,O49). Moreover, BNP levels were increased in AS 
patients with TVPG of 50 (60.5 +/- 10,3) mmHg or more (4351,4 pgiml; +/- 4699,5) in 
comparison to patients with TVPG less than 50 (29,9 +/- 16,6) mmHg (1373,6 pg/ml: +/- 
2176.8, P=O,O4). BNP levels ware correlated to the TVPG and AVA (w0.43 and wO.52, 
P<O.OOl), respectively. 
Conclusion: These results suggest BNP levels rncrease I” relation to the NPG and AVA. 
BNP measurement could potentially be used to monitor progression of disease non-inva- 
sively. This marker may also be useful to identify the optimum time for surgery in AS. 
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841-3 Mitral Annular Calcification, Aortic Sclerosis, and 
Incident Stroke in American Indians Free of Clinical 
Cardiovascular Disease 
Jorae R. Kizer, David 0. Wiebers, Jack P. Whisnant, James M. Galloway, Thomas K. 
Welty, Elisa T. Lee, Lyle Best, Mary J. Roman. Richard B. Devereux, Weill Medical 
College of Cornell University, New York, NY, Mayo Clinic, Rochester, MN 
While mitral annular calcification (MAC) 8 aortic sElerosis have been reported to be risk 
factors for cerebrovascular events, their relative prognostic significance Independent of 
other echo predictors is uncertain. We investigated the predictive value of MAC & aortic 
sclerosis for lncldent stroke while accounting for other proven echo predictors. Our 
cohort comprised American Indians in the Strong Heart Study having echo in 1993.95. 
Exclusion criteria: coronaty/valvular disease (aortic stenosis); prior stroke; atrlal flbrilla- 
tion; ejection fraction -< 35%; segmental wall motion abnormality. Follow-up was obtained 
through 12/99. N = 2659. Age = 56 y, women = 64%. hypertension = 54%, diabetes = 
47%. cholesterol/HDL = 4.7, body-mass index = 31 kg/m2, smoker = 31%, renal insuff- 
ciency = 2.3%, MAC = lo%, aortic sclerosis = 8% left atrial index = 2.2 cm/m, LV mass 
index = 40 g/m2 7. lncldent strokes = 60. MAC, but not aortic sclerosis, was a significant 
univariable predictor of stroke (Figure). In Cox models adjusting for all above factors, 
MAC emerged as an independent predictor of stroke (RR 2.2, P = 0.026). Aortic sclerosis 
was not predictive whether or not MAC was considered. Our findings demonstrate MAC 
to be a strong predictor of stroke independent of other echo risk factors, & are in line with 
other studies showing that aortic sclerosis is not independently predictive of cerebral 
events. In patients without overt cardiovascular disease, the isolated presence of MAC 
warrants aggressive primary prevention. 
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841-4 Does Aortic Valve Sclerosis Predict Cardiovascular 
Events Independently of Albuminuria in Hypertension? 
A LIFE Study 
Michael H. Olsen Kristian Wachtell, Jonathan N. Bella. Vittorio Palmieri, Eva Gerdts, 
Markku S. Nieminen. Gunnar Smith. Blbrn DahlBf. Hans Ibsen. Richard B. Devereux. , 
Glostrup University Hospital, Copenhagen, Denmark, The Weill Medical College of 
Cornell University, New York, NY 
Background: Aortic valve (AV) sclerosis and albuminuria are strong cardiovascular risk 
factors and they are both thought to be markers of atherosclerosis. In the LIFE study we 
investigated the predictive value of AV sclerosis for the composite endpoint (CEP) of car- 
diovascular death, non-fatal stroke or non-fatal myocardlal Infarctron correcting for urine 
albuminlcreatinine ratio (UACR) and other cardiovascular risk factors. 
Methods: After two weeks of placebo treatment, clinical, laboratory, and echocardio- 
graphic variables were assessed in 960 hypertensive patients from the LIFE Echo sub- 
study, aged 55-60 (mean 66*7) years, with electrocardiographic LV hypertrophy, and 
without known AV stenosis. Morning urine albumin and creatinine were measured, and 
urine albumin-creatinine ratio (UACR) was calculated. Macro- and microalbumlnuria 
were defined as UACRa5 and 3.5cUACR<35, respectively. AV sclerosis was defined as 
valve thickening or calcification. 15 patients with mild AV stenosis were excluded. 
Results: AV sclerosis was found in 366 patients and was associated with higher inci- 
dence of CEP (15.5% vs. 6.3%“). Micro- and macroalbuminuria were found in 143 
(17.1%) and 23 (2.6%) patients, respectively, and both were associated with higher Inci- 
dence of CEP (15% and 22% vs. 9.9%‘). The incidence of CEP increased progressively 
with micro- and macroalbummuria in oatients without AV sclerosis II 1.4% and 15.4% vs. 
8.3%‘) as well as in patients with AV sclerosis (19.2% and 30% vs. 12.7%‘). In Cox 
reoression analvses AV sclerosis was oredlctlve of the CEP [odds ratio IORl = 1.6’) inde- 
pendent of log UACR (I .5’); male gender (2.1”); and history of peripheral vascular dis- 
ease (2.5-I diabetes mellitus (2.3”) or cerebral vascular disease (2.4.‘). P<O.O5. 
